p mtor ser2448 Search Results


90
Novus Biologicals rabbit polyclonal anti phospho ser 2448 mtor
Rabbit Polyclonal Anti Phospho Ser 2448 Mtor, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti phospho ser 2448 mtor/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti phospho ser 2448 mtor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Bioss mtor (ser2448) polyclonal antibody
Mtor (Ser2448) Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtor (ser2448) polyclonal antibody/product/Bioss
Average 94 stars, based on 1 article reviews
mtor (ser2448) polyclonal antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

88
Rockland Immunochemicals p mtor ser 2448
P Mtor Ser 2448, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p mtor ser 2448/product/Rockland Immunochemicals
Average 88 stars, based on 1 article reviews
p mtor ser 2448 - by Bioz Stars, 2026-03
88/100 stars
  Buy from Supplier

90
Becton Dickinson p-mtor (ser2448) antibody
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
P Mtor (Ser2448) Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-mtor (ser2448) antibody/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
p-mtor (ser2448) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Wanleibio p-mtor (ser2448) antibody
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
P Mtor (Ser2448) Antibody, supplied by Wanleibio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-mtor (ser2448) antibody/product/Wanleibio
Average 90 stars, based on 1 article reviews
p-mtor (ser2448) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Beyotime anti p mtor (ser2448
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
Anti P Mtor (Ser2448, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p mtor (ser2448/product/Beyotime
Average 90 stars, based on 1 article reviews
anti p mtor (ser2448 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Abnova anti-p-mtor (ser2448)
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
Anti P Mtor (Ser2448), supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-p-mtor (ser2448)/product/Abnova
Average 90 stars, based on 1 article reviews
anti-p-mtor (ser2448) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Elabscience Biotechnology mtor antibody
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
Mtor Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtor antibody/product/Elabscience Biotechnology
Average 90 stars, based on 1 article reviews
mtor antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ZenBio ser2448-p-mtor #r381548 antibody
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
Ser2448 P Mtor #R381548 Antibody, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ser2448-p-mtor #r381548 antibody/product/ZenBio
Average 90 stars, based on 1 article reviews
ser2448-p-mtor #r381548 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Wuhan Sanying Biotechnology phosphorylated mammalian target of rapamycin (p-mtor) (ser2448) (67778-1-ig)
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
Phosphorylated Mammalian Target Of Rapamycin (P Mtor) (Ser2448) (67778 1 Ig), supplied by Wuhan Sanying Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphorylated mammalian target of rapamycin (p-mtor) (ser2448) (67778-1-ig)/product/Wuhan Sanying Biotechnology
Average 90 stars, based on 1 article reviews
phosphorylated mammalian target of rapamycin (p-mtor) (ser2448) (67778-1-ig) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Abmart Inc phosphorylated mtor ser2448 (p-mtor
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
Phosphorylated Mtor Ser2448 (P Mtor, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphorylated mtor ser2448 (p-mtor/product/Abmart Inc
Average 90 stars, based on 1 article reviews
phosphorylated mtor ser2448 (p-mtor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GenScript corporation anti-p-mtor ser2448
Antioxidant alters expression of p−STAT4 <t>and</t> <t>p−mTOR</t> from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.
Anti P Mtor Ser2448, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-p-mtor ser2448/product/GenScript corporation
Average 90 stars, based on 1 article reviews
anti-p-mtor ser2448 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Antioxidant alters expression of p−STAT4 and p−mTOR from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.

Journal: Antioxidants

Article Title: IL-21, Inflammatory Cytokines and Hyperpolarized CD8 + T Cells Are Central Players in Lupus Immune Pathology

doi: 10.3390/antiox12010181

Figure Lengend Snippet: Antioxidant alters expression of p−STAT4 and p−mTOR from SLE CD8 + T cells. CD8 + T cells were isolated from the PBMCs of SLE patients and treated with 2.5 μM menadione with or without NAC for 4 h and processed according to the protocol mentioned in the method section. Representative figure showing no modulation in p−STAT3 expression when treated with PMA/Ion, menadione (2.5 μM) or NAC (5 Mm) ( A ). Representative figures showing a reduction in p−STAT4 and p−mTOR following NAC (5 mM) treatment compared to their activation by PMA/Ion or treatment with menadione (2.5 μM) ( B , C ). Cumulative graphical representation showing changes in p−STAT3, p−STAT4 and p−mTOR after menadione and NAC treatment ( D – F ). Error bar indicates SEM. The experiments were done from 15 SLE patients ( n = 10) for p-STAT assay and ( n = 5) for p−mTOR assay, and all samples were tested for significance by using one-way ANOVA, followed by Tukey’s multiple comparison. p < 0.05 was considered statistically significant (*); p < 0.0001 was considered extremely significant (****), and ns means non-significant.

Article Snippet: After washing with staining media, cells were stained with p-mTOR (Ser2448) Antibody for 30 min at room temperature and then acquired on a BD LSR Fortessa [ , ].

Techniques: Expressing, Isolation, Activation Assay